olfactory receptor family 1 subfamily X member 1 pseudogeneGenealiases: []
Q-omics provides the consensus-scored OR1X1P profile across patient tissues and cancer cell-line models. OR1X1P expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in KIRC. Among the 18 cancer types available for tumor–normal comparison, OR1X1P is differentially expressed in 2, with the highest sampling consensus in HNSC. Additionally, OR1X1P RNA expression shows 6,668 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight KIRC, HNSC, and STAD as cancer lineages where OR1X1P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR1X1P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR1X1P survival associations across molecular data types. OR1X1P RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR1X1P RNA expression–survival associations across cancer types. High OR1X1P expression shows unfavorable associations in KIRC, STAD, ACC, TGCT and COAD, but favorable associations in HNSC. The KIRC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify KIRC as the clearest survival context for OR1X1P RNA expression.
This table summarizes OR1X1P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for OR1X1P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR1X1P shows higher tumor expression in HNSC and BLCA. The HNSC box plot shows higher OR1X1P RNA expression in tumor versus normal tissue (log2 FC = +0.030, t-test p = .036).
This table shows molecular features associated with OR1X1P in patient tissues and cancer cell lines. In patient samples, OR1X1P shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
